MedTrace Logo

Biological Therapy in Treating Women With Metastatic Breast Cancer

NCT00002780 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-12-19

No results posted yet for this study

Summary

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor cells.

PURPOSE: Phase I/II trial to study the effectiveness of T cells and interleukin-2 combined with peripheral stem cell transplantation or bone marrow transplantation in treating women who have stage IIIB or metastatic breast cancer.

Conditions

Interventions

BIOLOGICAL

aldesleukin

BIOLOGICAL

cytokine therapy

BIOLOGICAL

sargramostim

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

thiotepa

PROCEDURE

peripheral blood stem cell transplantation

Sponsors & Collaborators

  • St. Luke's Medical Center

    lead OTHER

Principal Investigators

  • John P. Hanson, MD · St. Luke's Medical Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002780 on ClinicalTrials.gov